Home › Bipolar Disorder › Virginia
Bipolar Disorder clinical trials in Virginia
4 studies for Bipolar Disorder are looking for participants at sites in Virginia.
Cities in Virginia
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Virginia Commonwealth University, Richmond
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 25, 2026 · NCT06372964Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Virginia Commonwealth University, Richmond
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Re:Cognition Health, Fairfax
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07286175A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Richmond
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.